Bacterial virulence factor inhibits caspase-4/11 activation in intestinal epithelial cells. by Pallett, MA et al.
Pallett, MA; Crepin, VF; Serafini, N; Habibzay, M; Kotik, O; Sanchez-
Garrido, J; Di Santo, JP; Shenoy, AR; Berger, CN; Frankel, G (2016)
Bacterial virulence factor inhibits caspase-4/11 activation in intesti-
nal epithelial cells. Mucosal immunology, 10 (3). pp. 602-612. ISSN
1933-0219 DOI: https://doi.org/10.1038/mi.2016.77
Downloaded from: http://researchonline.lshtm.ac.uk/4646461/
DOI: 10.1038/mi.2016.77
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-nd/2.5/
Bacterial Virulence Factor Inhibits Caspase-4/11 Activation in 
Intestinal Epithelial Cells
Mitchell A. Pallett1, Valerie F. Crepin1, Nicolas Serafini2,3, Maryam Habibzay1, Olga Kotik1, 
Julia Sanchez-Garrido4, James P. Di Santo2,3, Avinash R. Shenoy4, Cedric N. Berger1, and 
Gad Frankel1,#
1Department of Life Sciences, MRC Centre for Molecular Bacteriology and Infection, Imperial 
College London, UK
2Innate Immunity Unit, Institut Pasteur, Paris, France
3Inserm U668, Paris, France
4Department of Medicine, MRC Centre for Molecular Bacteriology and Infection, Imperial College 
London, UK
Abstract
The human pathogen enteropathogenic Escherichia coli (EPEC), as well as the mouse pathogen 
Citrobacter rodentium, colonize the gut mucosa via attaching and effacing lesion formation and 
cause diarrheal diseases. EPEC and C. rodentium type III secretion system (T3SS) effectors 
repress innate immune responses and infiltration of immune cells. Inflammatory caspases such as 
caspase-1 and caspase-4/11 are crucial mediators of host defense and inflammation in the gut via 
their ability to process cytokines such as IL-1β and IL-18. Here we report that the effector NleF 
binds the catalytic domain of caspase-4 and inhibits its proteolytic activity. Following infection of 
intestinal epithelial cells (IECs) EPEC inhibited caspase-4 and IL-18 processing in an NleF-
dependent manner. Depletion of caspase-4 in IECs prevented the secretion of mature IL-18 in 
response to infection with EPEC∆nleF. NleF-dependent inhibition of caspase-11 in colons of mice 
prevented IL-18 secretion and neutrophil influx at early stages of C. rodentium infection. Neither 
wild-type C. rodentium nor C. rodentium∆nleF triggered neutrophil infiltration or IL-18 secretion 
in Cas11 or Casp1/11 deficient mice. Thus, IECs play a key role in modulating early innate 
immune responses in the gut via a caspase-4/11 - IL-18 axis, which is targeted by virulence factors 
encoded by enteric pathogens.
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Introduction
Central to the infection strategy of the extracellular pathogens enteropathogenic Escherichia 
coli (EPEC), enterohaemorrhagic E. coli (EHEC)(1) and Citrobacter rodentium(2) is 
injection of type III secretion system effectors into intestinal epithelial cells (IECs) where 
they target diverse signalling pathways, particularly innate immune signaling. NleC and 
NleD are Zn-dependent endopeptidases that specifically cleave and disable RelA (p65) and 
JNK, respectively, thus blocking NF-κB and AP-1 activation(3). NleE is a methyltransferase 
that specifically modifies a cysteine in the zinc finger domain of TAB2 and TAB3 thus also 
blocking NF-kB signalling(4). NleB, which also inhibits NF-kB, has an N-
acetylglucosamine transferase activity that specifically modifies Arg 117 in the death 
domain of FADD(5,6) and NleH is a serine/threonine kinase that inhibits the RPS3/NF-κB 
pathway via phosphorylation of CRKL (v-Crk sarcoma virus CT10 oncogene-like protein)
(7).
Inhibition of innate immunity by EPEC and EHEC is needed to counter its activation by the 
T3SS, flagellins and lipopolysaccharides (LPS), which are readily detected by sensors and 
receptors in mammalian hosts. In response to infection, some sensors assemble 
macromolecular complexes called inflammasomes to stimulate the protease activity of 
caspase-1. The proteolytic processing and release of interleukin (IL)-1β and IL-18, and the 
induction of pyroptotic cell death triggered by caspase-1 can prevent the establishment and 
spread of microbial pathogens(8,9). In addition, the single mouse caspase-11 and the related 
human caspase-4 and caspase-5 act as cytosolic receptors, which bind LPS directly via their 
N-terminal caspase activation and recruitment domains (CARD, p22 domain). LPS binding 
induces oligomerization and autoproteolytic activation of caspase-4/5/11 into their active 
p20/p10 fragments and subsequent pyroptotic lysis of bacterially infected host cells(10). In 
human and mouse phagocytic cells LPS is detected by caspase-4/11, which stimulate 
caspase-1-dependent maturation of IL-1β and IL-18 via the NLRP3-ASC 
inflammasome(11–13). However, in IECs caspase-4/11 acts independently of NLRP3 and 
caspase-1 to directly process IL-18 and induce pyroptosis during Salmonella infection(14). 
Therefore the detection of Gram-negative bacteria by IECs markedly contrasts that in 
myeloid cells. However, unlike Salmonella, which are intracellular pathogens, extracellular 
pathogens use T3SS to prevent death pathways in host cells to which they intimately 
adhere(5,6,15). This suggests that EPEC, EHEC and C. rodentium might manipulate 
caspase-4/11 and/or inflammasome pathways in IECs.
Previous work on C. rodentium infections in mice showed that loss of inflammasome 
signaling related genes such as Nlrp3, Nlrc4, Casp1, Casp11, Il1β and Il18 results in 
enhanced morbidity and inflammatory disease, whereas wild-type mice clear the pathogen 
within 14-21 days(16,17). Detection of C. rodentium, EHEC and EPEC in myeloid cells has 
also been studied previously, and a recent report identified the EPEC NleA T3SS effector 
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protein as an inhibitor of NLRP3-caspase-1 inflammasomes(18). However, as IECs use non-
canonical, NLRP3- and caspase-1-independent mechanisms to detect bacteria, we 
hypothesized that EPEC and C. rodentium subvert caspase-4/11 action in IECs upon initial 
attachment. Here we report that bacterial T3SS effector NleF is a potent inhibitor of 
mammalian caspase-4/11 and thus prevents IL-18 secretion from IECs in vitro, and blocks 
caspase-11 – IL-18 mediated neutrophil influx during infection in vivo.
Results
NleF binds human caspase-4
The highly conserved effector NleF was previously reported to bind the active site and to 
inhibit the activity of caspase-9, caspase-8 and caspase-4, however, whether NleF affects 
inflammasome signaling and the innate immune response to bacterial infection in vivo has 
not been tested(19). By employing a yeast-2-hybrid screen (Table S1) and a direct yeast-2-
hybrid (DYH) assay (Fig. 1A) we confirmed that human caspase-4 is an interacting partner 
of EPEC NleF (NleFEPEC). Truncation analyses revealed an interaction between NleFEPEC 
and the p30 catalytic domain of caspase-4 (Fig. 1B). Deletion of four C-terminal residues in 
NleFEPEC (NleF1-185_EPEC) abrogates its binding to caspase-9(19), and similar defects were 
seen in binding to caspase-4 (Fig. 1B). Mutation of the substrate-binding pocket of 
caspase-4 (R152A, W313A and R314A) also abolished NleF-caspase-4 interaction (Fig. 
1B). To confirm that the binding is direct, the caspase-4 p20 subunit (22 kDa; His tagged), 
p10 subunit (10 kDa) and NleFEPEC (65 kDa; MBP fusion) were co-expressed, purified by 
tandem affinity chromatography and analyzed by gel filtration. Three chromatographic 
peaks corresponding to free MBP-NleFEPEC, free His-p20, and a complex containing 
NleFEPEC, p20 and p10 subunits were observed (Fig. 1C). NleFEPEC and caspase-4 subunits 
co-purified and co-eluted as a macromolecular complex with an apparent molecular weight 
(MW) of ~230 kDa (Fig. 1C-D).
NleF inhibits human caspase-4 and mouse caspase-11
Recombinant caspase-4 underwent auto-proteolytic activation presumably as a consequence 
of LPS binding when purified from E. coli. Wild-type caspase-4, but not a catalytic dead 
mutant (caspase-4C285S), underwent auto-proteolysis to the active p20 form and hydrolyzed 
the caspase-4 fluorogenic substrate peptide (Ac-LEVD-AFC; Fig. 2A). Recombinant 
NleFEPEC inhibited the activity of caspase-4 in a dose-dependent manner with an IC50 of 5 
nM (Fig. 2B), comparable to 14 nM previously measured for NleFEHEC by Blasche et al.
(19). Despite not binding caspase-4 in DYH, NleF1-185_EPEC, which was pulled down with 
caspase-4 at low levels (data not shown), was able to inhibit caspase-4 activity although at 
an IC50 of 25.5 nM (Fig. 2B). C. rodentium NleF (NleFCR), which shares 84% amino acid 
identity with NleFEPEC, strongly inhibited the proteolytic activity of mouse caspase-11 (IC50 
of 13 nM; Fig. 2C-D) revealing an evolutionarily conserved functional property. Importantly, 
we found that NleFEPEC inhibits caspase-4 more efficiently than NleFCR (Fig. 2C), while 
NleFCR inhibits caspase-11 more efficiently than caspase-4 (Fig. 2F).
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NleF inhibits h-caspase-4 activation during infection
To investigate if NleFEPEC targets caspase-4 during infection of human IECs, Caco-2 cells 
were infected with the wild-type (WT) EPEC and EPEC∆nleF; both strains adhered to the 
cultured cells equally (Fig. 3A). However, while secreted caspase-4 was absent following 
infection with WT EPEC, the active p30 fragment of caspase-4 was found in the 
supernatants of cells infected with EPEC∆nleF (Fig. 3B). Addition of the caspase-4 inhibitor 
Ac-LEVD-CHO complemented the EPEC∆nleF phenotype in a dose dependent manner 
(Fig. 3B).
NleFEPEC did not affect the expression of pro-IL-18, which was similar in uninfected cells 
and those infected with all the EPEC strains (Fig. 3C). While secretion of pro-IL-18 was 
detected upon infection with WT EPEC and EPECΔnleF, pro-IL-18 was only processed into 
the active form following infection with EPECΔnleF (Fig. 3D). Secretion of mature IL-18 
(mIL-18), induced by EPECΔnleF, was not detected when this strain was complemented 
with a plasmid encoding NleFEPEC (pNleFEPEC) (Fig. 3D).
To confirm that inhibition of caspase-4 by NleF was sufficient to block processing of IL-18, 
we generated Caco-2 cells depleted of caspase-4 using miRNA30E based stable shRNA 
expression (Fig. 4A). EPEC∆nleF infection of Caco-2 cells silenced for caspase-4 
expression (C4) did not secrete mIL-18, as measured by both western blotting (Fig. 4B) and 
ELISA (Fig. 4C), clearly pointing to a requirement of caspase-4 in IL-18 processing during 
EPEC infection of IECs. Importantly, no cell death was detectable by measuring LDH 
release or PI uptake following infection of control or caspase-4-depleted Caco-2 cells (Fig. 
4D); this is likely due to EPEC T3SS effectors (e.g. NleH, NleB), which inhibit cell 
death(5,6,15). Thus, in human IECs, pro-IL-18 processing during EPEC infection is 
caspase-4 dependent and the bacterially injected NleF specifically inhibits this process.
C. rodentium inhibits IL-18 secretion in vivo in an NleFCR-dependent manner
To test the role of NleF during infection in vivo we infected C57BL/6 mice with WT C. 
rodentium, C. rodentium∆nleF or C. rodentium∆nleF complemented with pnleFCR. 
Colonization (Fig. 5A) and colonic crypt hyperplasia (Fig. 5B) were similar between the 
different C. rodentium strains (Fig. 5). We quantified levels of IL-18 and IL-1β secreted 
from colonic explants, and the inflammasome-independent chemokine CXCL1 as a control, 
on days 4 and 8 post-infection (p.i.). On day 4 post infection of C57BL/6 mice with C. 
rodentium∆nleF we detected a significantly increased colonic secretion of IL-18, while 
mock-infected (PBS) or WT C. rodentium-infected colons released similarly low levels of 
IL-18 (Fig. 5C). Complementing the C. rodentium ∆nleF mutant with a plasmid encoding 
NleFCR restored the inhibition of IL-18 secretion (Fig. 5C); secreted IL-1β was below the 
detectable limit (data not shown). Secretion of CXCL1 was similar in colons extracted from 
mice treated with PBS or infected with WT C. rodentium or C. rodentium∆nleF (Fig. 5D). 
Complementing the C. rodentium ∆nleF mutant with a plasmid encoding NleFCR resulted in 
a significantly increased CXCL1 secretion (Fig. 5D), which is consistent with our recent 
finding that over expression of NleFEPEC activates NF-κB in cultured cells(20). Importantly, 
NleF-dependent inhibitory effects were only observed early during infection (day 4 p.i.), and 
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IL-18 secretion was similar following WT C. rodentium or C. rodentium ∆nleF infection on 
day 8 p.i. (Fig. 5E).
To validate that NleFCR inhibits IL-18 secretion via the inflammasomes, we first infected 
Casp1/11 deficient mice with C. rodentium and C. rodentium∆nleF. As expected, loss of 
Casp1 and Casp11 abolished IL-18 secretion from colonic explants after infection with WT 
C. rodentium or C. rodentium ∆nleF (Fig. 5C); CXCL1 secretion was similar in Casp1/11-/- 
mice infected with the two strains (data not shown). In order to confirm that the phenotype 
was due to caspase-11, we next infected Casp11-/- mice with C. rodentium or C. rodentium 
∆nleF. This showed that while WT C. rodentium and C. rodentium∆nleF colonized the 
Casp11-/- mice at comparable levels (Fig. 5F), secretion of IL-18 was extremely low and 
similar to that in Casp1/11-/- mice (Fig. 5C). We therefore concluded that caspase-11 is 
responsible for secretion of IL-18 following infection with C. rodentium ΔnleF.
IL-18 is essential for the recruitment of neutrophils early during C. rodentium infection
As IL-18 facilitates neutrophil and leukocyte recruitment to sites of inflammation(21), we 
investigated the effect of NleFCR on immune cell recruitment. Infection of C57BL/6 mice 
for 4 days with C. rodentium∆nleF resulted in a significant increase in neutrophil 
recruitment in comparison to WT C. rodentium-infected or PBS-treated mice (Fig. 6B). 
Infection with the C. rodentium ∆nleF pnleFCR strain restored the inhibition of neutrophil 
recruitment (Fig. 6B). No significant differences were observed for other myeloid or 
lymphocyte cell type analyzed, including macrophages, ILC, B-cells and T-cells (data not 
shown). Furthermore, correlating with similar IL-18 secretion, no difference in neutrophil 
recruitment was observed at day 8 post infection (Fig. 6C), suggesting that NleFCR plays a 
specific role during early immune responses to C. rodentium. Enhanced neutrophil influx 
was Casp1/11 dependent; absence of these caspases abolished the increase in neutrophil 
recruitment during infection with C. rodentium∆nleF (Fig. 6B). Similar results were 
obtained following infection of Casp11-/-mice (Fig. 6B). Thus NleFCR is a virulence factor 
responsible for early inhibition of the host inflammasomes, and that the inflammasome is 
essential for early neutrophil recruitment in response to C. rodentium infection.
Discussion
Inflammasome dependent cytokines and pyroptosis have important antimicrobial 
functions(8,9). It is therefore not surprising that pathogenic bacteria have evolved 
mechanisms to prevent inflammasome activation(22). For example, Yersinia uses YopK to 
prevent detection of its T3SS(22), and bacteria modify their LPS to evade detection by 
caspase-11(23). The Shigella flexneri effector OspC3 sequesters caspase-4 activity by 
binding the caspase-4 p20 subunit to prevent p10 binding and oligomerization(24). Here we 
demonstrate that a virulence factor of A/E pathogens, NleF, targets the heterotetramer 
complex of caspase-4 via its C-terminal motif, underlining the importance of caspase-4 
inhibition during the course of infection.
In agreement with our biochemical analyses, EPEC was able to inhibit caspase-4 in IECs in 
an NleF-dependent manner, while recent reports showed that infection of cultured cells with 
either Salmonella or EPEC led to caspase-4 activation(24) and caspase-4-dependent 
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induction of IL-18 release(14). Taken together, our data suggest that while EPEC can initiate 
caspase-4 activation and IL-18 processing, NleF dampens this response. Previous studies 
have shown that Nlrp3, Nlrc4, Casp1 and Casp11 are important in protection against C. 
rodentium infection(16,25). Loss of inflammasome-related genes results in significantly 
increased C. rodentium bacterial load in the intestine late in infection, which may partly 
explain the enhanced inflammation in inflammasome-deficient mice infected with C. 
rodentium. Loss of inflammasome-dependent IL-1β and IL-18 also results in enhanced 
bacterial burdens at late stages of infection and susceptibility to C. rodentium infection of 
Il1b-/- and Il18-/- mice(16). Our studies establish that NleF functions at early stages of 
infection of mucosal surfaces by inhibiting the inflammasome and preventing release of 
IL-18 by epithelial cells.
We also found that NleFCR inhibited caspase-11-dependent neutrophil recruitment. IL-18 is 
a key regulator of the adaptive immune response, stimulates the migration of innate and 
adaptive immune cells(21,26,27), and controls intestinal epithelial cell turnover and protects 
against damage in the intestine(28). During the early stages of infection, IL-18 is largely 
secreted by epithelial cells(17). Current data(16), including the secretion of IL-1β which is 
not expressed in non-hematopoietic cells(29), suggests that at later time points during C. 
rodentium infection colonic IL-18 secretion may switch to be myeloid cell dependent(16). 
Therefore, myeloid cell secretion of the IL-1 family cytokines may not be subverted by 
NleFCR and would become the pre-dominant source of IL-18 and IL-1β at the peak of 
infection. Similarly secretion of IL-22 is switched from ILC3 at early phase of infection to 
IL-22-producing T cells at later time points (> 7 days)(30).
The study demonstrates a pathway during infection of IECs, which leads to the activation of 
caspase-11, secretion of IL-18 and recruitment of neutrophil. In addition, we show that 
inhibition of caspase-11 by bacterial NleF blocks this pathway in the host. Our findings are 
consistent with the recent study on the epithelial cell caspase-11–IL-18 axis during 
Salmonella infection, which reported significant neutrophil influx in infected gall bladder 
epithelia of wild-type mice, but no neutrophil influx in Casp11-/- mice(31).
Recent studies have revealed the contribution of non-inflammasome and inflammasome-
forming NLRs in the non-hematopoietic compartment for intestinal homeostasis and the host 
mediated clearance and protection against enteric pathogens(35). Mice deficient in NLRP6 
have impaired goblet cell mucus exocytosis and display a microbiome exposed epithelial cell 
layer and persistence of C. rodentium infection(36). Moreover, NLRP12 is a checkpoint for 
non-hematopoietic non-canonical NF-κB activation(37), and acts as a negative regulator of 
colitis and colitis-associated colon cancer. Furthermore, IEC-expressed NLRC4 mediates 
early innate immune responses against C. rodentium via an unknown mechanism 
independent of IL-1 family cytokine secretion(38). Here we show that the caspase-4/11 
dependent IECs inflammasome is crucial for IL-18 cytokine maturation and the early innate 
immune response to EPEC/ C. rodentium. Consistently with this, Song-Zhao et al.(17) 
recently suggested, based on studies of Nlrp3-/- and Asc-/- mice, that early protection to C. 
rodentium infection is mediated by IECs independently of NLRP3 activation. Taken 
together, our study identifies a fundamental and novel role for the T3SS effector NleF in the 
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pathogenesis and virulence of A/E pathogens through the inhibition of the newly 
characterized IECs caspase-4/11 dependent inflammasome.
Methods
Strains, oligonucleotides, plasmids and antibodies
Strains, plasmids and primers used in this study are listed in Tables S2-S3 respectively. nleF 
was amplified from EPEC E2348/69 and C. rodentium ICC169 genomic DNA by PCR. Site-
directed mutagenesis was carried out by inverse PCR using KOD Hot Start polymerase and 
mismatch primers. All constructs were confirmed by sequencing (GATC biotech). For 
Western Blot, Mouse monoclonal anti-caspase-4 clone 4B9 (sc-56056; Santa Cruz), anti-α-
Tubulin clone DM1A (T6199), mouse polyclonal antibody anti-caspase-11 p20 clone A-2 
(sc-374615; Santa cruz) and anti-pro-IL-18 (CPTC-IL18-1; DSHB), the rabbit monoclonal 
anti-IL-18 (PM014; MBL), anti-caspase-5 (4429; Cell signalling) and the rabbit polyclonal 
antibody anti-GFP (Ab290; Abcam) were used as primary antibodies. Horse radish 
peroxidase (HRP)-conjugated goat anti-rabbit IgG (Fc fragement; catalog no.111-035-008; 
Jackson immunoresearch) and HRP-conjugated goat anti-mouse IgG (Fc fragement; catalog 
no, 115-035-008; Jackson immunoresearch) were used as secondary antibodies.
Retroviral transductions and stable knockdown cell lines
Micro-RNA30 based (miR-30; Table S1) gene silencing constructs were generated in pMX-
CMV-YFP using one-step sequence and ligation independent cloning (SLIC) (36) following 
the optimized miR-30E vector design(39). Sequences were as follows: CASP4 - 
CGACTGTCCATGACAAGAT; and LacZ (non-targeting negative control) 
ACGTCGTATTACAACGTCGTGA. The miR-30E plasmids were transfected using 
Lipofectamine 2000 (Invitrogen), along with the packaging plasmids pVSV-G and pCMV-
MMLV-pack(40) into HEK293E cells to produce a VSV-G pseudotyped retroviral particles 
for transduction. After 48 h supernatants were filtered through 0.45 μm syringe filters and 
added directly to pre-seeded Caco-2 TC7 cells. Transduced cells were selected by 
puromycin (Gibco Invitrogen) at 10 μg.ml-1 and knockdown was confirmed by western 
blotting.
EPEC infection, ELISA and Western blotting
Caco-2 TC7 cells (ATCC) were seeded at 7.5 x104/ml and upon reaching confluence (7 
days) the medium was changed every day for 7 the following 7 days. Before infection the 
cells were starved for 3 h in serum free DMEM. Monolayers were infected with primed 
EPEC(20) at an MOI of 1:10 for 3 h. The cells were then washed twice in PBS and the 
medium was replaced with serum free DMEM-high glucose plus penicillin and streptomycin 
at 100 U/ml and 100 μg/ml, respectively. After 1 h cells were washed and either processed 
for Western Blot (total IL-18) or incubated for a further 17 h (secreted caspase-4 and IL-18) 
with or without Ac-LEVD-CHO (Enzo Lifesciences). Supernatants were collected, cleared 
by centrifugation at 13000 rpm at 4 °C for 10 min and precipitated for Western blotting with 
the addition of 10 % (v/v) trichloroacetic acid for 17 h at 4 ºC. The concentration of IL-18 in 
cell supernatant (MBL) was determined by ELISA according to the manufacturer’s protocol.
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Cell adhesion and cytotoxicity assays
Caco-2 TC7 were infected with the WT EPEC, EPEC∆nleF and the complemented strain 
(pnleFEPEC) for 3 h. The monolayers were lysed in 1 % PBS/triton X-100 and EPEC 
attachment was enumerated by serial dilution on LB-Agar and calculation of colony forming 
units (CFU).
Supernatants of uninfected cells or cell infected with EPEC for 21 h were harvested and the 
level of LDH release was measured using CytoTox 96® Non-Radioactive Cytotoxicity 
Assay (Promega). As a control for total LDH, cell lysis buffer (1 % Triton-X100/ PBS) was 
added for 30 min at 37 ºC directly to the medium and cell layer. Absorbance was measured 
at 490 nm using the FluoStar Omega plate reader and results are displayed as percentage of 
total release corresponding to the LDH measured in the supernatant divided by the total 
LDH.
Alternatively the media was removed and cell layers were incubated in 3.3 μg/ml propidium 
iodide (Invitrogen) in warm PBS (PI/PBS) for 15 min and fluorescence was measured at an 
excitation of 510 nm and emission of 610 nm using the FluoStar Omega plate reader. As a 
control PI/PBS alone was measured or cell lysis buffer (0.05 % Triton X-100/PBS) 
supplemented with 3.3 μg/ml propidium iodide was added for 15 min at 37ºC. Results are 
displayed as a percentage of total PI uptake.
Yeast-2-hybrid screen and yeast direct hybrids
A yeast-2-hybrid screen was conducted using pGKBT7-nleFEPEC and the HeLa cell cDNA 
Library following the manufacturer’s Handbook (Clontech). AH109 were co-transformed 
with pGBT9-bait and pGADT7-prey (Table S3) and plated onto Difco Yeast Nitrogen Base 
without amino acids (SD) agar supplemented with 2% glucose, 20 mg/L adenine 
hemisulfate, 20 mg/L arginine HCl, 20 mg/L histidine HCl monohydrate, 30 mg/L 
isoleucine, 30 mg/L lysine HCl, 20 mg/L methionine, 50 mg/L phenylalanine, 200 mg/L 
threonine, 30 mg/L tyrosine, 20/L mg uracil, 150 mg/ml valine and lacking tryptophan and 
leucine (Double Drop-out; DDO) for selection of transformed clones. Clones positive for 
both plasmids were re-streaked on to SD DDO and SD QDO /-His/-Ade supplemented with 
40 mg/L x-α-gal (SD QDO) for selection of positive interactions.
Recombinant Protein expression and purification
E. coli BL21 Star expressing pET28-NleFEPEC (pICC1659), pET28-NleF1-185-EPEC 
(pICC1660) and pET28-NleFCR (pICC1839) were cultured for 16 h in LB at 37 °C at 200 
rpm. Bacteria were sub-cultured at 1:100 into 1 L LB supplemented with 50 μg/ml 
kanamycin and incubated at 37°C at 200 rpm until OD600 of 0.4-0.6. Cultures were then 
induced with 0.5 mM IPTG for 18 h at 18°C. Cells were harvested by centrifugation at 
10000 rpm for 20 min and re-suspended in 30 ml ice cold His-lysis buffer (20 mM Tris-HCl 
pH 7.9, 0.5 M NaCl, and 5 mM Imidazole). The cells were lysed by Emulsiflex following 
the manufacturer’s instructions (Emulsiflex-B15; Avestin) and centrifuged at 14000 rpm for 
a further 30 mins at 4°C. Supernatant was removed and applied to 5 ml His resin (Novagen) 
pre-charged in 5 mM NiSO4 and pre-equilibrated in His-lysis buffer and rocked at 4°C for 
1.5 h. Samples were applied to a Poly-Prep Chromatography column (Qiagen) and flow-
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through was collected. The column was washed twice with 20 ml His-lysis buffer and once 
in 20 ml wash buffer (Tris-HCl pH 7.9, 0.5 M NaCl, and 60 mM Imidazole). His-tagged 
fusion proteins were eluted with 10 x 1 ml elution buffer (His-lysis buffer supplemented 
with 1 M Imidazole). Fractions containing His-purified NleF were checked by SDS-PAGE 
gel electrophoresis and further purified by size exclusion (Akta prime) with a Superdex75 
column (GE Healthcare; 10/300GL).
Co-purification of the caspase-4-NleFEPEC complex
BL21 Star cells were co-transformed with pACYC-DUET-1-CASP4C258S His-p20/p10 and 
pMAL-c2x-nleFEPEC. Bacterial pellets were re-suspended in 20mM Tris-HCl pH 7.4, 250 
mM NaCl and lysed by sonication and purified by amylose affinity chromatography. 
Bacterial lysates were incubated with amylose resin for 1.5 h at 4 °C and then washed with 
50 ml wash buffer (20 mM Tris-HCl pH 8.0, 250 mM NaCl and eluted with wash buffer 
supplemented with 10 mM maltose. The co-elute was dialysed and then purified further by 
IMAC talon affinity chromatography, as described previously(41). Complex formation was 
analysed by size exclusion (Akta prime) with a Superdex200 column (GE Healthcare) using 
the Gel Filtration Markers Kit for Protein Molecular Weights 12,000-200,000 Da (Sigma-
Aldrich) to determine complex size. Size exclusion fractions were verified by SDS PAGE 
gel and confirmed by Mass spectrometry.
Caspase activity assays
BL21 star were transformed with pET28a-empty, pET28a-CASP4, pET28a-CASP4 C258S 
or pET28a-Casp11. Soluble lysates at 200 μg/ml were incubated with or without 50 μM Ac-
LEVD-AFC (Enzo Life Sciences) in 20 mM PIPES, 100 mM NaCl, 10 mM DTT, 1 mM 
EDTA, 0.1% CHAPS, 10% sucrose pH 7.2 or 20 mM Tris, 250 mM NaCl pH 7.4 for 
caspase-11 and caspase-4, respectively. Purified recombinant His-NleF derivatives were 
added at varying concentrations from 50 nM to 1 pM. Fluorescence was measured in 5 min 
intervals at 37 °C using an excitation of 410 nm and emission of 520 nm using the FLUOstar 
Omega plate reader (BMG Labtech).
Construction of C. rodentium mutant
C. rodentium strain ICC169 ∆nleF (ICC1129) was generated using a modified version of the 
lambda red-based mutagenesis system(42). Briefly, the nleF gene and its flanking regions 
were PCR-amplified from WT C. rodentium ICC169 genomic DNA using the primers pair 
NleF-up-Fw/NleF-down-Rv and cloned into pC-Blunt-TOPO vector (Invitrogen). The nleF 
gene was then excised using inverse-PCR (primers NleF-up-Rv-BamHI/NleF-down-Fw-
BamHI) and the resulting linear product was BamHI digested, allowing insertion of the non-
polar aphT(43), cassette, resulting in plasmid pICC1674. After verifying for correct 
orientation of the kanamycin cassette, the insert was PCR-amplified using NleF-up-Fw and 
NleF-down-Rv primers. The PCR products were electroporated into wild type C. rodentium 
expressing the lambda red recombinase from pKD46 plasmid. The deletion was confirmed 
by PCR and DNA sequencing amongst the kanamycin resistant clones (primers NleF-up-
Fw-check and NleF-down-Fw-check).
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Oral infection of mice
Pathogen-free female C57BL/6 mice were either purchased from Charles River or sourced 
from BIME Institut Pasteur. Casp1/11-/- mice were generously provided by Bernhard Ryffel 
(TAAM-CDTA, Orelans, France) and Casp11-/- were generously provided by Mohamed 
Lamkanfi (Ghent University, Belgium). All animals were housed in individually HEPA-
filtered cages with sterile bedding and free access to sterilized food and water. Independent 
infection experiments for wild-type C57BL/6, Casp1/11-/- and Casp11-/- mice were 
performed using 3 to 8 mice per group. Mice were infected and followed for shedding as 
described(44). Briefly, mice were infected via oral gavage with 109 WT C. rodentium or C. 
rodentium ∆nleF as described previously. For control, mice were gavaged with sterile PBS. 
The number of viable bacteria used as inoculum was determined by retrospective plating 
onto LB agar containing antibiotics. Stool samples were recovered aseptically at various 
time points after inoculation and the number of viable bacteria per gram of stool was 
determined by plating onto LB agar(44).
Sample collection and colonic crypt hyperplasia measurement
Segments of the terminal colon (0.5 cm) of each mouse were collected, flushed and fixed in 
10% neutral buffered formalin. Formalin fixed tissues were then processed, paraffin-
embedded, sectioned at 5 μm and stained with haematoxylin and eosin (H&E) using 
standard techniques. H&E stained tissues were evaluated for colonic crypt hyperplasia 
microscopically without knowledge of the treatment condition used in the study and the 
length of at least 100 well-oriented crypts from each section from all of the mice per 
treatment group (n=4-6) were evaluated. H&E stained tissues were imaged with an Axio 
Lab.A1 microscope (Carl Zeiss MicroImaging GmbH Germany), images were acquired 
using an Axio Cam ERc5s colour camera, and computer-processed using AxioVision (Carl 
Zeiss MicroImaging GmbH, Germany).
Sample collection for cytokine analysis and flow cytometry
Isolation of colonic cells and flow cytometry were performed as described(44). After a PBS 
wash, the 5th cm of the distal colon was incubated in RPMI containing penicillin, 
streptomycin, gentamicin and FBS at 37°C for 24 h. The concentrations of IL-18 
(eBioscience, #BMS618/3), IL-1β and KC (CXCL1; R&D Systems) were determined by 
ELISA according to the manufacturer’s protocols.
Statistics
All data was analyzed using GraphPad Prism software, using the Mann-Whitney test and 
represented as the mean +/- standard error of mean or standard deviation. A P value less than 
0.05 (P<0.05) was considered statistically significant.
Supplementary Materials
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. NleF binds caspase-4.
(A) A direct yeast two hybrid assay revealed that NleFEPEC, but not NleF1-185_EPEC, 
interacts with full-length and p30 caspase-4. (B) Substitution of amino acids R152A, 
W313A and R314A within the putative caspase-4 substrate domain abrogated the interaction 
with NleFEPEC. (C) Fractions of size exclusion of the chromatographic profile of MBP-
NleFEPEC and His-p20/p10 caspase-4 purified by amylose and talon affinity chromatography 
and (D) analyzed by SDS-PAGE gel electrophoresis, revealed that NleFEPEC and caspase-4 
subunits co-purified and co-eluted as a macromolecular complex at a MW of ~230 kDa.
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Fig. 2. NleF inhibits caspase-4 activity.
(A) Recombinant caspase-4, but not caspase-4C258S, is auto-activated (western blot) and 
cleaves the reporter Ac-LEVD-AFC. Results are plotted as relative fluorescence units (RLU) 
minus background (No Ac-LEVD-AFC) over time (min). (B) Dose-dependent inhibition of 
caspase-4 Ac-LEVD-AFC cleavage by recombinant NleFEPEC, and NleF1-185_EPEC (shown 
by Coomassie stained gel). (C) NleFEPEC (10 nM) inhibits the activity of caspase-4 more 
efficiently than NleFCR (10nM) after 30 min incubation in the presence of Ac-LEVD-AFC. 
(D) Recombinant caspase-11 is auto-activated (western blot) and cleaves the reporter Ac-
LEVD-AFC. (E) Dose dependent inhibition of caspase-11 activity by recombinant NleFCR 
(shown by Coomassie stained gel). (F) NleFCR (50 nM) inhibits the activity of caspase-11 
more efficiently than NleFEPEC (50nM) after 30 min incubation in the presence of Ac-
LEVD-AFC. Results are expressed as a percentage of wild-type caspase-4 or caspase-11 
RLU/min from at least two independent experiments. * indicates P<0.05.
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Fig. 3. NleF inhibits secretion of caspase-4 and IL-18 during EPEC infection.
(A) Infection of polarized Caco-2 cells with WT EPEC, EPEC∆nleF or the complemented 
strain (pnleFEPEC) revealed similar levels of cell adhesion (3 h post infection). (B) Caco-2 
cells were infected with WT EPEC or EPEC∆nleF in the absence or presence of the inhibitor 
Ac-LEVD-CHO (total 21 h). Immunoblotting of supernatants (SN) revealed that EPEC 
inhibits secretion of active caspase-4 (~28 kDa) in an NleFEPEC-dependent manner, assessed 
by western blots (upper panel) and quantified by densitometry of multiple experiments 
(lower panel). (C) Infection of Caco-2 cells with WT EPEC, EPEC∆nleF or complemented 
EPEC∆nleF (pnleFEPEC) had no effect on the levels of total IL-18 at 4 h p.i. (D) NleF is 
essential for inhibition of IL-18 secretion from infected Caco-2 cells (21 h post infection).
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Fig. 4. NleFEPEC inhibits IL-18 secretion in an caspase-4 dependent manner.
(A) Western blots showing knockdown of caspase-4, but not capsapse-5, by miRNA30E. (B) 
Infection of Caco-2 cells (21 h) depleted of caspase-4 (C4) revealed that it is essential for 
IL-18 processing in response to infection with EPEC∆nleF, assessed by western blots (upper 
panel) and quantified by densitometry of two independent experiments (lower panel). (C) 
ELISA from two biological repeats showing specific secretion of IL-18 from control (YFP), 
but not from C4, Caco-2 cells infected for 21 h with EPEC∆nleF. (D) EPEC does not trigger 
LDH release or PI uptake during infection (21 h) of control or C4 Caco-2 cells, results are 
represented as a percentage of total uptake or total release and are an average of two 
biological repeats carried out in triplicate. * indicates P<0.05.
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Fig. 5. NleFCR inhibits colonic IL18 secretion 4 days p.i.
WT C. rodentium, C. rodentium∆nleF and the complemented strain (∆nleF pnleFCR) 
similarly colonized and triggered colonic hypoplasia in C57BL/6 mice (A and B). Each dot 
in B represents an individual measurement of crypt length (from at least 20 measurements 
per section per mouse), and horizontal bars represent mean values. Significant increase in 
secreted IL-18, measured by ELISA, was seen specifically following infection of C57BL/6 
with C. rodentium∆nleF (day 4), but not following infection of either Casp1/11-/- or 
Casp11-/- mice (day 4) (C) or C57BL/6 (day 8) (E). Secreted CXCL1 was found in similar 
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levels, except for the complemented strain, which triggered greater secretion of CXCL1 (D). 
No difference in colonization of Casp11-/- mice was seen following infection with WT C. 
rodentium or C. rodentium∆nleF (E). * indicates P<0.05.
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Fig. 6. NleFCR inhibits colonic neutrophil recruitment 4 days p.i.
C57BL/6, Casp1/11-/- and Casp11-/- mice were infected with WT C. rodentium, C. 
rodentium∆nleF or complemented C. rodentium∆nleF (∆nleF pnleFCR). (A) Representative 
image of flow cytometry gating strategy for neutrophils (CD11b+Ly6G+) of control (PBS) 
and infected C57BL/6 mice. The number of neutrophils (CD11b+Ly6G+) present within the 
myeloid gate was counted from C57BL/6 (B-C, days 4 and 8 post infection), Casp1/11-/- or 
Casp11-/- (B, day 4 post infection) mice (at least six mice per condition). * indicates P<0.05.
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